# Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin

Study · id `cardio:ct-nct02791035` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02791035](<https://clinicaltrials.gov/study/NCT02791035>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02791035

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02791035. Allocation not applicable; no masking; primary purpose other. Start 2016-06 (registry gives no type); primary completion 2017-03 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02791035, source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02791035, source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)
- Primary completion: 2017-03 (actual) (ClinicalTrials.gov record NCT02791035, source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)
- Completion: 2017-03 (actual) (ClinicalTrials.gov record NCT02791035, source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02791035, source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02791035-2017-07-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Oral administration of Ipragliflozin
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Severance Hospital
- Collaborator class: OTHER
- Collaborator: Samsung Medical Center
- Collaborator class: OTHER
- Collaborator: Kyung Hee University Hospital at Gangdong
- Collaborator class: OTHER
- Collaborator: Astellas Pharma Korea, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Severance Hospital (`cardio:org-severance-hospital`)
- Registry lists this organization as a collaborator: Samsung Medical Center (`cardio:org-samsung-medical-center`)
- Registry lists this organization as a collaborator: Kyung Hee University Hospital at Gangdong (`cardio:org-kyung-hee-university-hospital-at-gangdong`)
- Registry lists this organization as a collaborator: Astellas Pharma Korea, Inc. (`cardio:org-astellas-pharma-korea-inc`)

## Provenance

Content hash: b6835c80b77080267659b0f9f996245bdf963676683086419f4d77c5aaae3923
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
